Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Momede Pharmaceutical is a prominent Chinese pharmaceutical enterprise focused on the integration of Traditional Chinese Medicine (TCM) with modern drug manufacturing. The company is widely recognized for its Qixuehe brand, particularly its flagship Qixuehe Capsules used for treating blood stasis and various gynecological issues. Beyond women's health, Momede produces a diverse range of products covering cardiovascular, respiratory, and musculoskeletal therapeutic areas. The company maintains extensive GMP-certified production lines and a robust distribution network throughout mainland China. It is recognized as a National High-tech Enterprise and is a key player in the pharmaceutical industry of the Shaanxi province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 陕西摩美得制药.